Published in J Immunol on March 01, 1988
Purification and characterization of a novel monocyte chemotactic and activating factor produced by a human myelomonocytic cell line. J Exp Med (1989) 4.64
Human keratinocytes are a source for tumor necrosis factor alpha: evidence for synthesis and release upon stimulation with endotoxin or ultraviolet light. J Exp Med (1990) 2.62
Effects of cytokines on intracellular growth of Brucella abortus. Infect Immun (1993) 2.33
Role of L3T4+ lymphocytes in protective immunity to systemic Candida albicans infection in mice. Infect Immun (1989) 1.56
In vivo activation of macrophage oxidative burst activity by cytokines and amphotericin B. Infect Immun (1990) 1.42
Th1 CD4+ lymphocytes delete activated macrophages through the Fas/APO-1 antigen pathway. Proc Natl Acad Sci U S A (1995) 1.40
Pathological role of osteoclast costimulation in arthritis-induced bone loss. Proc Natl Acad Sci U S A (2007) 1.32
Tumor necrosis factor alpha augments nitric oxide-dependent macrophage cytotoxicity against Entamoeba histolytica by enhanced expression of the nitric oxide synthase gene. Infect Immun (1994) 1.25
Tumor necrosis factor and wound healing. Ann Surg (1990) 1.19
The role of TNF-alpha in the pathogenesis of type 1 diabetes in the nonobese diabetic mouse: analysis of dendritic cell maturation. Proc Natl Acad Sci U S A (2005) 0.99
Regulation of murine macrophage function by IL-4: IL-4 and IFN-gamma differentially regulate macrophage tumoricidal activation. Immunology (1993) 0.97
Francisella tularensis-induced in vitro gamma interferon, tumor necrosis factor alpha, and interleukin 2 responses appear within 2 weeks of tularemia vaccination in human beings. J Clin Microbiol (1991) 0.94
Treatment of neuroinflammation by soluble tumor necrosis factor receptor Type II fused to a thermally responsive carrier. J Neurosurg Spine (2008) 0.82
Reconfigurable microfluidics with integrated aptasensors for monitoring intercellular communication. Lab Chip (2014) 0.81
Solution structure and basis for functional activity of stromal cell-derived factor-1; dissociation of CXCR4 activation from binding and inhibition of HIV-1. EMBO J (1997) 4.04
An essential regulatory role for macrophage migration inhibitory factor in T-cell activation. Proc Natl Acad Sci U S A (1996) 3.79
Inflammation dampened by gelatinase A cleavage of monocyte chemoattractant protein-3. Science (2000) 3.75
Production of prostaglandin E and an interleukin-1 like factor by cultured astrocytes and C6 glioma cells. J Immunol (1982) 3.24
Matrix metalloproteinase activity inactivates the CXC chemokine stromal cell-derived factor-1. J Biol Chem (2001) 3.03
Release of tumor necrosis factor-alpha from macrophages. Enhancement and suppression are dose-dependently regulated by prostaglandin E2 and cyclic nucleotides. J Immunol (1988) 2.58
Structure-activity relationships of chemokines. J Leukoc Biol (1995) 2.15
Migration inhibitory factor expression in experimentally induced endotoxemia. Am J Pathol (1997) 2.00
Programmed cell death (apoptosis) in human monocytes infected by influenza A virus. Immunobiology (1994) 1.98
The ligands of CXC chemokine receptor 3, I-TAC, Mig, and IP10, are natural antagonists for CCR3. J Biol Chem (2000) 1.86
Persistent long-term changes in lymphocyte subsets induced by polyclonal antibodies. Transplantation (1997) 1.64
Enhanced release of cytokines, interleukin-2 receptors, and neopterin after long-distance running. Clin Immunol Immunopathol (1992) 1.51
Kinetics of the transformation of Gram-negative rods to spheroplasts and ghosts by serum. J Immunol (1966) 1.51
Susceptibility of mononuclear phagocytes to influenza A virus infection and possible role in the antiviral response. J Leukoc Biol (1997) 1.51
Influenza A virus infection of macrophages. Enhanced tumor necrosis factor-alpha (TNF-alpha) gene expression and lipopolysaccharide-triggered TNF-alpha release. J Immunol (1991) 1.39
Role of macrophage cytokines in influenza A virus infections. Immunobiology (1993) 1.39
Tumor necrosis factor-alpha production of influenza A virus-infected macrophages and potentiating effect of lipopolysaccharides. J Immunol (1990) 1.36
Interleukin 1 and the glomerular mesangium. I. Purification and characterization of a mesangial cell-derived autogrowth factor. J Immunol (1986) 1.34
Chemokines in the cerebrospinal fluid of patients with meningitis. Clin Immunol Immunopathol (1996) 1.31
Increase of CCR1 and CCR5 expression and enhanced functional response to MIP-1 alpha during differentiation of human monocytes to macrophages. J Leukoc Biol (2001) 1.30
Activation of glomerular mesangial cells by the terminal membrane attack complex of complement. J Immunol (1987) 1.30
Coxsackievirus B3-induced production of tumor necrosis factor-alpha, IL-1 beta, and IL-6 in human monocytes. J Immunol (1992) 1.25
Macrophages release arachidonic acid, prostaglandin E2, and thromboxane in response to late complement components. J Immunol (1984) 1.24
N-terminal peptides of stromal cell-derived factor-1 with CXC chemokine receptor 4 agonist and antagonist activities. J Biol Chem (1998) 1.22
Prostaglandin synthesis in spleen cell cultures of mice injected with Corynebacterium parvum. Cell Immunol (1978) 1.20
Isolated cysticercosis of the breast masquerading as a breast tumour: report of a case and review of literature. Ann Trop Med Parasitol (2011) 1.20
Characterization of blood mononuclear cells of rheumatoid arthritis patients. I. Depressed lymphocyte proliferation and enhanced prostanoid release from monocytes. Clin Immunol Immunopathol (1982) 1.18
The effects of phagocytosis, dextran sulfate, and cell damage on PGE1 sensitivity and PGE1 production of macrophages. J Immunol (1978) 1.17
Selective induction of monocyte and not neutrophil-attracting chemokines after influenza A virus infection. J Exp Med (1996) 1.17
Infection of macrophages by influenza A virus: characteristics of tumour necrosis factor-alpha (TNF alpha) gene expression. Res Virol (1997) 1.15
Macrophage activation by granulocyte/macrophage colony-stimulating factor. Priming for enhanced release of tumor necrosis factor-alpha and prostaglandin E2. J Immunol (1989) 1.13
Granulocyte-colony stimulating factor and lipopolysaccharide regulate the expression of interleukin 8 receptors on polymorphonuclear leukocytes. J Biol Chem (1995) 1.13
Macrophage cytotoxicity: interleukin 1 as a mediator of tumor cytostasis. J Immunol (1986) 1.13
Differential mononuclear leukocyte attracting chemokine production after stimulation with active and inactivated influenza A virus. Cell Immunol (1998) 1.11
MIF expression in the rat brain: implications for neuronal function. Mol Med (1998) 1.10
Defense against influenza A virus infection: essential role of the chemokine system. Immunobiology (2001) 1.07
Induction of cytokines and chemokines in human monocytes by Mycoplasma fermentans-derived lipoprotein MALP-2. Infect Immun (1999) 1.07
Chemokines and serpentines: the molecular biology of chemokine receptors. J Leukoc Biol (1993) 1.07
Macrophage-activating factors from different T cell clones induce distinct macrophage functions. J Immunol (1983) 1.06
Release of cyclic AMP from macrophages by stimulation with prostaglandins. J Immunol (1975) 1.06
Recognition and imitation of pantomimed motor acts after unilateral parietal and premotor lesions: a perspective on apraxia. Neuropsychologia (2001) 1.05
Immune response to recombinant mycobacterial proteins in patients with tuberculosis infection and disease. J Infect Dis (1996) 1.05
Enhancement of glomerular mesangial cell neutral proteinase secretion by macrophages: role of interleukin 1. J Immunol (1986) 1.04
Control of prostanoid synthesis: role of reincorporation of released precursor fatty acids. Prostaglandins (1986) 1.03
Drugs which disrupt microtubules do not inhibit the initiation of lymphocyte activation. Nature (1977) 1.01
Lysozyme and serum bactericidal action. Nature (1966) 1.01
Application of GaN-based ultraviolet-C light emitting diodes--UV LEDs--for water disinfection. Water Res (2010) 1.00
Immune-interferon (IFN-gamma), macrophage-activating factors (MAFs), and colony-stimulating factors (CSFs) secreted by T cell clones in limiting dilution microcultures, long-term cultures, and by T cell hybridomas. Immunol Rev (1983) 0.97
Systemic macrophage stimulation in rats with silicosis: enhanced release of tumor necrosis factor-alpha from alveolar and peritoneal macrophages. Am J Respir Cell Mol Biol (1991) 0.97
Induction of prostaglandin E release from macrophages by colchicine. J Immunol (1980) 0.95
Characterization of a high molecular weight tumor necrosis factor-alpha mRNA in influenza A virus-infected macrophages. J Immunol (1994) 0.95
Membrane perturbation and stimulation of arachidonic acid metabolism. Mol Immunol (1982) 0.95
Activation of macrophages by lymphokines from T-cell clones: evidence for different macrophage-activating factors. Mol Immunol (1984) 0.94
Time course of chemokines in the cerebrospinal fluid and serum during herpes simplex type 1 encephalitis. J Neurol Sci (1998) 0.93
Differential desensitization of lipopolysaccharide-inducible chemokine gene expression in human monocytes and macrophages. Eur J Immunol (2000) 0.93
Enhancement of the PGE1 response of macrophages by concanavalin A and colchicine. J Immunol (1977) 0.93
Activation of glomerular mesangial cells by gram-negative bacterial cell wall components. Am J Pathol (1988) 0.92
Effect of granulocyte/macrophage colony-stimulating factor on human monocytes infected with influenza A virus. Enhancement of virus replication, cytokine release, and cytotoxicity. J Immunol (1993) 0.92
Enhancement of tumor necrosis factor-alpha gene expression by low doses of prostaglandin E2 and cyclic GMP. Immunobiology (1990) 0.91
Induction of neutrophil-attracting chemokines in transforming rat hepatic stellate cells. Gastroenterology (1997) 0.91
Lipopolysaccharide suppresses cytokine release from coxsackie virus-infected human monocytes. Res Immunol (1992) 0.91
Experimental silicosis: a shift to a preferential IFN-gamma-based Th1 response in thoracic lymph nodes. Am J Physiol Lung Cell Mol Physiol (2000) 0.90
Influenza A virus infects macrophages and stimulates release of tumor necrosis factor-alpha. Pathobiology (1991) 0.90
Induction of prostanoid synthesis in human platelets by the late complement components C5b-9 and channel forming antibiotic nystatin: inhibition of the reacylation of liberated arachidonic acid. J Immunol (1985) 0.89
Suppression of proinflammatory cytokines and induction of IL-10 in human monocytes after coxsackievirus B3 infection. J Med Virol (2001) 0.89
Regulation of prostaglandin synthesis by protein kinase C in mouse peritoneal macrophages. Biochem J (1989) 0.88
Contribution of immunoglobulins M and G, complement, and properdin to the intracellular killing of Escherichia coli by polymorphonuclear leukocytes. Infect Immun (1978) 0.88